You are here Home Guidance and resources Resources International scientific guidelines adopted in Australia International scientific guideline: Points to consider on switching between superiority and non-inferiority CPMP/EWP/482/99 adopted by the Therapeutic Goods Administration (TGA) Listen Print Share LinkedIn (Twitter) Facebook Email Loading... About this guideline Overseas effective date: 29 June 2001 Categories: Clinical efficacy and safety | Biostatistics Access this international scientific guideline TGA annotations Please note that there is no requirement in Australia to demonstrate superiority. For more information see International scientific guidelines adopted in Australia. Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.